ESC Congress 2026 Abstract
Cholesterol goals unmet in adults entering oral drug trial
The 3,053 participants’ average “bad” cholesterol level was 2.30 mmol/L despite the most intensive oral cholesterol-lowering treatment they could tolerate.The 3,053 participants’ average “bad” cholesterol level was 2.30 mmol/L despite the most intensive oral cholesterol-lowering treatment they could tolerate.
Randomized trial · 3,053 peopleInterventions
Who was studied3,053 adults with or at high risk for ASCVD, one year
What changedAverage LDL cholesterol was 2.30 mmol/L despite maximally tolerated oral cholesterol-lowering treatment
The catchEnrollment required elevated LDL cholesterol, selecting for unmet cholesterol goals
